Citations for
1CDK4, CDK6, TFE3, TFEB
CDK4/6 regulate lysosome biogenesis through TFEB/TFE3. 2020 PMID:
Yin Q, Jian Y, Xu M, Huang X, Wang N, Liu Z, Li Q, Li J, Zhou H, Xu L, Wang Y, Yang C.
J Cell Biol. Aug 3;219(8):e201911036. doi: 10.1083/jcb.201911036. 2020
2CDK4, CDK6, RPS14
Ribosomal Proteins Control Tumor Suppressor Pathways in Response to Nucleolar Stress
Lessard F, Brakier-Gingras L, Ferbeyre G.
Bioessays. Mar;41(3):e1800183. doi: 10.1002/bies.201800183. Epub 2019 Feb 1. 2019
3CCND1, CDK4, SHCBP1
SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD, Yuan YL, Yu HB, Tian GJ, Li DY.
Oncol Rep Mar;41(3):1649-1657. doi: 10.3892/or.2018.6952. Epub 2018 Dec 21 2018
4CCND1, CCNE1, CDK2, CDK4, CIAPIN1
The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.
Huang Z, Su GF, Hu WJ, Bi XX, Zhang L, Wan G.
Eur Rev Med Pharmacol Sci 21(13):3054-3060. 2017
5CDK4, CDK6
CDK4-CDK6 inhibitors induce autophagy-mediated degradation of DNMT1 and facilitate the senescence antitumor response.
Bourdeau V, Ferbeyre G.
Autophagy utophagy. 2016 Aug 17:1-2. [Epub ahead of print] 2016
6CDK4, LAT2, RUNX1T1
Runx1t1 (Runt-related transcription factor 1; translocated to, 1) epigenetically regulates the proliferation and nitric oxide production of microglia.
Baby N, Li Y, Ling EA, Lu J, Dheen ST.
PLoS One 9(2):e89326. doi: 10.1371/journal.pone.0089326. eCollection 2014. 2014
7CDK4, CDK6
Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
Rodríguez-Díez E, Quereda V, Bellutti F, Prchal-Murphy M, Partida D, Eguren M, Kollmann K, Gómez de Cedrón M, Dubus P, Cañamero M, Martínez D, Sexl V, Malumbres M.
Blood 124(15):2380-90. doi: 10.1182/blood-2014-02-555292. Epub 2014 Aug 25. 2014
8CCND1, CDK4, STK38, STK38L
Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
Du Z, Tong X, Ye X.
J Biol Chem 288(37):26678-87. doi: 10.1074/jbc.M113.466433. Epub 2013 Jul 29. 2013
9CDK1, CDK4, CDK5, UCHL1
Ubiquitin C-terminal hydrolase L1 (UCH-L1) acts as a novel potentiator of cyclin-dependent kinases to enhance cell proliferation independently of its hydrolase activity.
Kabuta T, Mitsui T, Takahashi M, Fujiwara Y, Kabuta C, Konya C, Tsuchiya Y, Hatanaka Y, Uchida K, Hohjoh H, Wada K.
J Biol Chem 288(18):12615-26. doi: 10.1074/jbc.M112.435701. Epub 2013 Mar 29. 2013
10CCND1, CDK4, YY1
Yin Yang-1 inhibits tumor cell growth and inhibits p21WAF1/Cip1 complex formation with cdk4 and cyclin D1.
Ishii H, Hulett MD, Li JM, Santiago FS, Parish CR, Khachigian LM.
Int J Oncol 40(5):1575-80. doi: 10.3892/ijo.2012.1362. Epub 2012 Feb 9. 2012
11CCND1, CDK4
Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma.
Ciznadija D, Liu Y, Pyonteck SM, Holland EC, Koff A.
Cancer Res 71(19):6174-83. doi: 10.1158/0008-5472.CAN-11-1031. Epub 2011 Aug 15. 2011
12CDK4, MDM2
Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL.
Genes Chromosomes Cancer 49(6):518-25.PMID: 20196171 2010
13CDK4
Role of Cdk4 in lymphocyte function and allergen response.
Chow YH, Zhu XD, Liu L, Schwartz BR, Huang XZ, Harlan JM, Schnapp LM.
Cell Cycle 9(24):4922-30. Epub 2010 Dec 15. 2010
14CDK4
Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass.
Lee JH, Jo J, Hardikar AA, Periwal V, Rane SG.
PLoS One 5(1):e8653. doi: 10.1371/journal.pone.0008653. 2010
15CDK2, CDK4, NPM2
Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
Adon AM, Zeng X, Harrison MK, Sannem S, Kiyokawa H, Kaldis P, Saavedra HI.
Mol Cell Biol 30(3):694-710. doi: 10.1128/MCB.00253-09. Epub 2009 Nov 23. 2010
16CDK4
Crystal structure of human CDK4 in complex with a D-type cyclin.
Day PJ, Cleasby A, Tickle IJ, O'Reilly M, Coyle JE, Holding FP, McMenamin RL, Yon J, Chopra R, Lengauer C, Jhoti H.
Proc Natl Acad Sci U S A 106(11):4166-70. Epub 2009 Feb 23. 2009
17CDK4
The structure of CDK4/cyclin D3 has implications for models of CDK activation.
Takaki T, Echalier A, Brown NR, Hunt T, Endicott JA, Noble ME.
Proc Natl Acad Sci U S A 106(11):4171-6. Epub 2009 Feb 23. 2009
18ASIP, CDK4, CDKN2A, CMM1, CMM2, CMM20, CMM3, CMM4, MC1R, TYR, TYRP1
Genetic risk factors for melanoma.
Meyle KD, Guldberg P.
Hum Genet 126(4):499-510. Epub 2009 Jul 8. Review. 2009
19CDK4
Migratory localization of cyclin D2-Cdk4 complex suggests a spatial regulation of the G1-S transition.
Wang Z, Xie Y, Zhang L, Zhang H, An X, Wang T, Meng A.
Cell Struct Funct 33(2):171-83. Epub 2008 Oct 1. 2008
20PPP3CA, CDK4
Mitotic regulation of CDK4 by the serine/threonine phosphatase, calcineurin.
Chow R, Olesen J, Onyskiw C, Baksh S.
Biochem Biophys Res Commun 363(3):506-12. Epub 2007 Sep 17. 2007
21CDK4, CDK6
CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
Ruas M, Gregory F, Jones R, Poolman R, Starborg M, Rowe J, Brookes S, Peters G.
Mol Cell Biol 27(12):4273-82. Epub 2007 Apr 9. 2007
22CDK4, JUND
Induced JunD in intestinal epithelial cells represses CDK4 transcription through its proximal promoter region following polyamine depletion.
Xiao L, Rao JN, Zou T, Liu L, Marasa BS, Chen J, Turner DJ, Passaniti A, Wang JY.
Biochem J 403(3):573-81. 2007
23CDK4, CMM3
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, Akslen LA.
Genes Chromosomes Cancer 44(1):10-8. 2005
24PSMD10, CDK4, PSMC4
Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome.
Dawson S, Apcher S, Mee M, Higashitsuji H, Baker R, Uhle S, Dubiel W, Fujita J, Mayer RJ.
J Biol Chem 277(13):10893-902. Epub 2002 Jan 04. 2002
25CDK4, HMGA2, MDM2
Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases.
Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, Saeter G, Knuutila S, Myklebost O.
Cancer Genet Cytogenet 125(2):100-11. 2001
26CDK4, MYC
Identification of CDK4 as a target of c-MYC.
Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW.
Proc Natl Acad Sci U S A 97(5):2229-34. 2000
27CDK4, CDKN2A
CDK4 gene amplification in osteosarcoma : reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
Wei G, et al.
Int J Cancer 80 : 199-204. 1999
28CDK4
Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.
An HX, et al.
Am J Pathol 154(1):113-8. 1999
29CDK4
Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia.
Rane SG, et al.
Nat Genet 22(1):44-52. 1999
30CDK4, CDKN2A
Normal repair of ultraviolet radiation-induced DNA damage in familial melanoma without CDKN2A or CDK4 gene mutation.
Shannon JA, et al.
Melanoma Res 9(2):133-7. 1999
31CDK4, CDKN2A, CMM3
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France.
Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, Benard J, Bressac-de Paillerets B.
Hum Mol Genet 7(2):209-16. 1998
32BCL2, BCL8, BRINP1, CDK4, GLI1, MDM2, MYC, REL
Chromosomal and gene amplification in diffuse large B-cell lymphoma.
Rao PH, et al.
Blood 92 : 234-240. 1998
33CDK4, CMM3
Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma.
Guldberg P, Kirkin AF, Gronbaek K, thor Straten P, Ahrenkiel V, Zeuthen J.
Int J Cancer 72(5):780-3. 1997
34CDK4, CMM3
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
Zuo L, et al.
Nat Genet 12 : 97-99. 1996
35CDK4, MCM7
Shared role of the pRB-related p130 and p107 proteins in limb development.
Cobrinik D, et al.
Genes Dev 10 : 1633-1644. 1996
36CDK4, CDKN2A, CMM2, TSG9A
Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma : analysis of a clinic-based population.
Fitzgerald MG, et al.
Proc Natl Acad Sci U S A 93 : 8541-8545. 1996
37CDK4, MDM2, TSPAN31
Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
Reifenberger G, et al.
Cancer Res 56 : 5141-5145. 1996
38CDK4, DDIT3, GLI1, MDM2
Mapping of gene loci in the Q13-Q15 region of chromosome 12.
Mitchell ELD, et al.
Chromosome Res 3 : 261-262. 1995
39CDK4, CMM3
A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
Wšlfel T, et al.
Science 269 : 1281-1284. 1995
40CDK2, CDK4, CDK5
Chromosomal mapping of human CDK2,CDK4, and CDK5 cell cycle kinase genes.
Demetrick DJ, et al.
Cytogenet Cell Genet 66 : 72-74. 1994
41CDKN2A, TSG9A, CDK4
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Schmidt EE, et al.
Cancer Res 54 : 6321-6324. 1994
42CDK4, CDK6
CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.
Bates S, et al.
Oncogene 9 : 71-79. 1994